Evidence map›Paper›PMID 41383968›Full record

ArticleFrontiers in veterinary science2025

Resistance evolution under potentiated sulphonamide pressure in

Ádám Kerek, Bence Török, Ábel Szabó, Levente Laczkó, Gábor Kardos, Krisztián Bányai, Eszter Kaszab, Krisztina Bali, Ákos Jerzsele

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ádám KerekDepartment of Pharmacology and Toxicology, University of Veterinary Medicine Budapest, Budapest, Hungary.
Bence TörökDepartment of Pharmacology and Toxicology, University of Veterinary Medicine Budapest, Budapest, Hungary.
Ábel SzabóDepartment of Pharmacology and Toxicology, University of Veterinary Medicine Budapest, Budapest, Hungary.
Levente LaczkóOne Health Institute, University of Debrecen, Debrecen, Hungary.
Gábor KardosNational Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, University of Veterinary Medicine Budapest, Budapest, Hungary.
Krisztián BányaiDepartment of Pharmacology and Toxicology, University of Veterinary Medicine Budapest, Budapest, Hungary.
Eszter KaszabNational Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, University of Veterinary Medicine Budapest, Budapest, Hungary.
Krisztina BaliNational Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, University of Veterinary Medicine Budapest, Budapest, Hungary.
Ákos JerzseleDepartment of Pharmacology and Toxicology, University of Veterinary Medicine Budapest, Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Antimicrobial resistance (AMR) poses an escalating global health threat. Potentiated sulphonamides are widely used in both veterinary and human medicine. This study aimed to investigate the Methods: The MEGA-plate evolutionary model was used to expose Results: In strains adapted to 1000 × potentiated sulphonamide, MIC values significantly increased for most tested antibiotics. Mutations were identified in key folate pathway genes ( Discussion: These findings underscore the need for cautious use of combination antimicrobials, as they may elicit pleiotropic resistance responses beyond their intended targets.

Indexed as

AMRco-selectionEscherichia coliMEGA-platemicroevolutionNGSpotentiated sulphonamideresistance development

Identifiers

PMID41383968
PMCPMC12690934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.